100% agree and i like many others wont be accepting any offers under what Zantrene would be worth if it proves itself in the next lot of P2 trials starting up in the 2nd half of the year, im glad that we have had a glimpse of what cardio is worth so we at least have a baseline on where the offers need to at least start before we even start thinking of any acceptances. Again we still need to prove it out in the next lot of trials even though there is previous data to come to some early conclusions on the outcome
General Comments / Chat, page-7341
-
- There are more pages in this discussion • 3,765 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.91 |
Change
0.025(1.33%) |
Mkt cap ! $317.6M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.93 | $1.85 | $166.3K | 88.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2049 | $1.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.91 | 200 | 1 |
View Market Depth
| Last trade - 13.04pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |